Cargando…

Higher doses of naloxone are needed in the synthetic opiod era

There has been a dramatic increase of deaths due to illicit fentanyl. We examined the pharmacology of fentanyl and reviewed data on the number of repeat doses of naloxone used to treat fentanyl overdoses. Multiple sequential doses of naloxone have been required in a certain percentage of opioid over...

Descripción completa

Detalles Bibliográficos
Autores principales: Moss, Ronald B., Carlo, Dennis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379922/
https://www.ncbi.nlm.nih.gov/pubmed/30777088
http://dx.doi.org/10.1186/s13011-019-0195-4
_version_ 1783396210574360576
author Moss, Ronald B.
Carlo, Dennis J.
author_facet Moss, Ronald B.
Carlo, Dennis J.
author_sort Moss, Ronald B.
collection PubMed
description There has been a dramatic increase of deaths due to illicit fentanyl. We examined the pharmacology of fentanyl and reviewed data on the number of repeat doses of naloxone used to treat fentanyl overdoses. Multiple sequential doses of naloxone have been required in a certain percentage of opioid overdoses due to fentanyl. In addition, fentanyl appears to differ from other opioids as having a very rapid onset with high systemic levels found in overdose victims. A rapid competition is required by naloxone to out-compete large numbers of opioid receptors occupied by fentanyl in the CNS. Taken together, we propose that higher doses of naloxone are needed to combat the new era of overdoses due to the more potent synthetic opioids such as fentanyl.
format Online
Article
Text
id pubmed-6379922
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63799222019-02-28 Higher doses of naloxone are needed in the synthetic opiod era Moss, Ronald B. Carlo, Dennis J. Subst Abuse Treat Prev Policy Debate There has been a dramatic increase of deaths due to illicit fentanyl. We examined the pharmacology of fentanyl and reviewed data on the number of repeat doses of naloxone used to treat fentanyl overdoses. Multiple sequential doses of naloxone have been required in a certain percentage of opioid overdoses due to fentanyl. In addition, fentanyl appears to differ from other opioids as having a very rapid onset with high systemic levels found in overdose victims. A rapid competition is required by naloxone to out-compete large numbers of opioid receptors occupied by fentanyl in the CNS. Taken together, we propose that higher doses of naloxone are needed to combat the new era of overdoses due to the more potent synthetic opioids such as fentanyl. BioMed Central 2019-02-18 /pmc/articles/PMC6379922/ /pubmed/30777088 http://dx.doi.org/10.1186/s13011-019-0195-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
Moss, Ronald B.
Carlo, Dennis J.
Higher doses of naloxone are needed in the synthetic opiod era
title Higher doses of naloxone are needed in the synthetic opiod era
title_full Higher doses of naloxone are needed in the synthetic opiod era
title_fullStr Higher doses of naloxone are needed in the synthetic opiod era
title_full_unstemmed Higher doses of naloxone are needed in the synthetic opiod era
title_short Higher doses of naloxone are needed in the synthetic opiod era
title_sort higher doses of naloxone are needed in the synthetic opiod era
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379922/
https://www.ncbi.nlm.nih.gov/pubmed/30777088
http://dx.doi.org/10.1186/s13011-019-0195-4
work_keys_str_mv AT mossronaldb higherdosesofnaloxoneareneededinthesyntheticopiodera
AT carlodennisj higherdosesofnaloxoneareneededinthesyntheticopiodera